Cormorant Asset Management, LP Pharvaris N.V. Transaction History

Cormorant Asset Management, LP

$992 Million
Q2 2025

A detailed history of Cormorant Asset Management, LP transactions in Pharvaris N.V. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 1,454,660 shares of PHVS stock, worth $31.5 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares

1,454,660

Previous 1,466,460 0.8%

Holding current value

$31.5 Million

Previous $23 Million 11.2%

% of portfolio

2.58%

Previous 2.44%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$11.83 - $18.66 $139,594 - $220,188	-11,800 Reduced 0.8%	1,454,660 $25.6 Million
Q2 2024 Aug 14, 2024	SELL	$15.67 - $24.59 $3.84 Million - $6.02 Million	-245,000 Reduced 14.32%	1,466,460 $27.6 Million
Q4 2023 Feb 14, 2024	BUY	$15.2 - $28.05 $5.32 Million - $9.82 Million	350,000 Added 25.71%	1,711,460 $48 Million
Q3 2023 Nov 14, 2023	BUY	$14.68 - $21.4 $5.69 Million - $8.3 Million	387,846 Added 39.84%	1,361,460 $28.4 Million
Q2 2023 Aug 14, 2023	BUY	$7.82 - $16.0 $1.23 Million - $2.51 Million	157,154 Added 19.25%	973,614 $14.7 Million
Q4 2022 Feb 14, 2023	SELL	$1.98 - $11.46 $774,259 - $4.48 Million	-391,040 Reduced 32.38%	816,460 $9.19 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $25.8 $472,065 - $1.59 Million	61,547 Added 5.37%	1,207,500 $9.26 Million
Q2 2022 Aug 15, 2022	BUY	$16.35 - $27.5 $7.54 Million - $12.7 Million	461,065 Added 67.32%	1,145,953 $25.3 Million
Q1 2022 May 16, 2022	SELL	$15.98 - $19.65 $77,391 - $95,164	-4,843 Reduced 0.7%	684,888 $12.4 Million
Q3 2021 Nov 15, 2021	SELL	$13.14 - $20.97 $724,434 - $1.16 Million	-55,132 Reduced 7.4%	689,731 $12.2 Million
Q2 2021 Aug 16, 2021	SELL	$18.05 - $29.59 $2.15 Million - $3.53 Million	-119,280 Reduced 13.8%	744,863 $13.6 Million
Q1 2021 May 17, 2021	BUY	$25.25 - $40.11 $21.8 Million - $34.7 Million	864,143 New	864,143 $23.8 Million

Others Institutions Holding PHVS

# of Institutions

Shares Held

39.2M

Call Options Held

Put Options Held

View Full List

About Pharvaris N.V.

Ticker PHVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,766,000
Market Cap $731M
Description
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...

More about PHVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account

Cormorant Asset Management, LP Pharvaris N.V. Transaction History